» Articles » PMID: 34918196

Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis

Overview
Date 2021 Dec 17
PMID 34918196
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Psoriasis is a chronic, autoimmune, inflammatory skin disease affecting 2-4% of the general population, which nowadays is even perceived as a systemic illness. The nature of this dermatosis may negatively influence patients' general condition, life expectancy, and quality of life, which highlights the severity of the problem and the need to perform further investigation. We aimed to assess quality of life, stress severity, and physical activity of patients with psoriasis in relation to demographic and clinical data and comparison to the control group without dermatoses.

Methods: A set of surveys was conducted in 56 patients with psoriasis hospitalized at the Department of Dermatology, Medical University of Bialystok. Questionnaires used involved the Dermatology Life Quality Index, WHO Quality of Life questionnaire, International Questionnaire of Physical Activity, and a self-invented stress survey. Obtained data were compared to a sex- and age-matched control group without dermatoses. Statistical analysis was performed using GraphPad Prism.

Results: Patients with psoriasis were found to be significantly less satisfied with their health and had lower scores in WHO social, environmental, and psychological domains, comparing to controls. Patients reported higher stress severity and lower satisfaction with sex life and physical appearance than controls. Patients with psoriasis also tended to perform less intensive physical activity than controls.

Conclusions: This study highlights the perception of psoriasis as not only affecting skin but also having a multifactorial impact on psychological and internal condition. Described lifestyle abnormalities can be easily evaluated with validated questionnaires, which could be introduced to patients in order to raise their awareness of comorbidities and mobilize them to modify incorrect lifestyle habits. Screening for other disorders and introduction of a holistic approach to every patient could be beneficial because the improvement of patients' life quality is one of the most important issues.

Citing Articles

Pathophysiology and Treatment of Psoriasis: From Clinical Practice to Basic Research.

Gao Y, Xu T, Wang Y, Hu Y, Yin S, Qin Z Pharmaceutics. 2025; 17(1).

PMID: 39861704 PMC: 11769081. DOI: 10.3390/pharmaceutics17010056.


Breakthrough Psoriasis in Patients Receiving Biologicals.

Damsin T, Absil G, Libon F, Tassoudji N, Nikkels A Psoriasis (Auckl). 2025; 15():1-8.

PMID: 39781106 PMC: 11705962. DOI: 10.2147/PTT.S502382.


Association of psoriasis disease with physical activity and exercise: systematic review and meta-analysis.

Zhu H, Sun Q, Choi H, Li Y, Zhang W Postepy Dermatol Alergol. 2024; 41(5):450-455.

PMID: 39606610 PMC: 11589643. DOI: 10.5114/ada.2024.143424.


[Mental disorders from climate and environmental changes using the example of dermatology].

Dohm L, Saha S, Fronhoffs K, Gieler U Dermatologie (Heidelb). 2024; 75(9):704-710.

PMID: 39117980 DOI: 10.1007/s00105-024-05396-7.


Managing the Patient with Psoriasis and Metabolic Comorbidities.

Bellinato F, Maurelli M, Geat D, Girolomoni G, Gisondi P Am J Clin Dermatol. 2024; 25(4):527-540.

PMID: 38748391 PMC: 11193697. DOI: 10.1007/s40257-024-00857-0.


References
1.
Kurd S, Troxel A, Crits-Christoph P, Gelfand J . The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010; 146(8):891-5. PMC: 2928071. DOI: 10.1001/archdermatol.2010.186. View

2.
Mansouri P, Valirad F, Attarchi M, Mohammadi S, Hatami S, Mircheraghi S . The Relationship between Disease, Work and Sickness Absence among Psoriasis Patients. Iran J Public Health. 2016; 44(11):1506-13. PMC: 4703230. View

3.
Frankel H, Han J, Li T, Qureshi A . The association between physical activity and the risk of incident psoriasis. Arch Dermatol. 2012; 148(8):918-24. PMC: 4102422. DOI: 10.1001/archdermatol.2012.943. View